Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Febbo Phillip G.Chief Medical Officer2017-02-16Sell2,49520,644$30.0975.07-3.2620,644 (Direct)
Cole G BradleyCOO2017-02-15Sell5,00039,728$291450.3839,728 (Direct)
Shak StevenChief Scientific Officer2017-01-23Sell5,000327,207$27.28136.46.71327,207 (Direct)
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.1-0.3835,882 (Direct)
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.05-4.935,882 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2016-12-05Sell5,000289,594$30.02150.1-3.0359,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-8.2614,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-8.2327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.4-1.9235,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.440.859,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.95-4.21327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.59-4.8435,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.04-1.9226,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.158.5327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.646.235,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.26.86327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227027.74
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.350.8335,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.221.2929,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.16.16327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.29.2735,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8512.96327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.19.3535,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.923.9632,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.61385.4734,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.017.0215,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$28563.9631,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.314.47326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.083.9624,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-9.436,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-8.1427,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-13.4424,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-0.5127,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-0.7512,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-0.7524,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1211.8330,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9814.8330,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.125.7430,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9610.9430,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.165.729,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-6.94Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-4.3729,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-8.77Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-8.5729,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-2.51Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-7.221,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-8.836,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-13Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-11.76Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-10.4921,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-16.4Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-17.6522,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-19.676,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-5.43Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.081.1822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-2.38Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-3.2622,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.26.4312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2111.66Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.779.48Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.227.6222,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271897.81312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.118.9312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.311.53Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.485.3924,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.786.6722,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.629.68Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3616.0223,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7510.9311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27817.8122,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.522.64311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.284.8622,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.584.4115,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.666.32311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27817.8124,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-7.62308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-2.97Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.513.3418,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-1.56308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-5.12Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-12.4521,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-16.646,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-15.82Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-12.7421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-7.2318,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-1.89308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-2.97Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-2.818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-13.7313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-15.16Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-10.5118,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-11.5221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-7.566,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-11.73318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-11.87Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-12.1921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-12.1921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-13.5219,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-17.61318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-15.89Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-13.917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-13.917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-12.6613,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-13.16323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-18.41Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-18.8717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-20.1813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-19.5
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-20.7
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-20.036,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-21.09
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-21.18
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-22.337,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-21.73327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-20.14
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-18.766,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-15.23
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-15.437,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-16.11Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-19.1817,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-19.1212,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-2.97Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.484.7512,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.431.8912,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.584.79
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.43.487,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.52.52,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.962.21
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.533.41
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.083.8514,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.541.186,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.53.9617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.74.4114,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.74.94333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.954.75Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$28843.9617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.684.566,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.128.5288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.78.05338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.268.2636,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.526.55288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.26.86Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.14.67288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$28843.9617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.551.7114,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-12Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-17.42343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-13.8517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-13.8211,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-16.3514,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-13.77348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-8.14Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-16.8514,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-17.32,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-16.8353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-16.16Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-4.5314,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-18.916,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-14.98358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-16.25Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-17.75Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-19.0314,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-12.45363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-12.74Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-12.74Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-13.21Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-14.3113,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-13.88367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-9.76
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-11.8726,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-14.08
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-14.96Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-13.5917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-2.84
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-3.67Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.180.8313,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.692.32
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.423.196,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.654.22372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.954.75Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.984.0418,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.81.82Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-3.8613,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-3.22377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-3.19Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-3.19Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-3.22377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-6.3419,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-6.25Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-2.7713,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-3.32
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-3.32
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-3.32
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-2.35
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-2.35
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-2.35
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.190.17
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.60.17
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.710.17
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52852.14Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.73.45382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.383.74
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.83.74
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.13.74
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-0.78
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-0.89
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-0.89
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.761.2220,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.711.2220,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.611.19Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2410.43
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0910.43
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1310.43
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.611.19Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.189.9714,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.025.826,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.110.18Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.19.35Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.78.86382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$28283.9617,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.855.77,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.26.01Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1511.83387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.86.67Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.481.827,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.633.52
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.725.24
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.163.52
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3112.35
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1612.22
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7812.35
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3511.66392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.985.05
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.665.05
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.536.44
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.196.9
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.486.9
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.86.86Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.528.66
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.59.447,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7412.22
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4912.22
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9418.91
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1631.846,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.833.78392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.627.51Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5530.487,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.239.88Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.231.847,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.126.46392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.819.11Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1515.247,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1515.247,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.910.066,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.055.43392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.26.41,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.74.947,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.67.34392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9112.3518,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.813.311,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1211.15
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9211.15
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6811.11
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4511.197,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.616.47
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.066.44
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.36.44
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7513.93392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.489.9319,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.29.19Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8312.267,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0811.79Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.914.7Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9214.2Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3214.97Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.212.13Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.558.18Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2519.06Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3219.84Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7922.36Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3219.84Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.413.62Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3811.83Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0815.38Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7816.16Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1216.16Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4414.38Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0613.31Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.713.31Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9224.45Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2124.45Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3525.1Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5129.32Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0829.32Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244431.13Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.237.64Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.237.64Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8738.22Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.633.96Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6531.54Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6828.18Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.229.61Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.628.58Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514066.34Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.161.36Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.459.33Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279108.67Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7892.78Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.495.76Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5393.94Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1596.56Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9296.56Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64101.31Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13101.31Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07102.57Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73102.57Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81100.48Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3100.48Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9494.2Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6194.2Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5693.17Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4296.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7696.03Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.594.07Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.297.89Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5899.25Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2399.25Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2897.36Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2127.24Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41123.07Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283105.72Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04107.19Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2484.47Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6883.43Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.286.48Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.887.69Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.472.55Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.572.25Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1472.45Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538949.67Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338650.83Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4850.13Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3249.67Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7946.8Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1570.73Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7970.73Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.668.95Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7866.25Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5271.13Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9471.13Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3469.84Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2568.75Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8766.63Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.644.68Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9542.77Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8442.56Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8843.82Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7843.68Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.251.54Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3345.26Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8845.62Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5845.55Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2540.97Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.142.56Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9240.9Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179837.51Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6537.77Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6540.42Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0440.83Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1444.68Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8540.15Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7445.7Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2745.7Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6845.7Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9145.7Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6549.05Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010045.55Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4449.36Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8849.28Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.849.36Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8849.36Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0449.9Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1749.44Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1181.82
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1181.82
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6259.33
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8964.56
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199553.21
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9161.99
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6261.99
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8161.99
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4561.99
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.644.68
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5249.59
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7248.9
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.148.9
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4648.9
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8248.9
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2847.62
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6414.29
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9715.2
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.850.05
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5552.17
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.635.27
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3641.31
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3641.31
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.239.62
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8549.97
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0244.32
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1151.22
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1151.22
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.858.21
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9846.5
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9846.5
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.645.19
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.744.32
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3242.98
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.429.32
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3528.41
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4833.59
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6526.95
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0328.29
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0822.98
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460620.09
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1222.52
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125238.62
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1551.14
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20245.55
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0446.13
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7746.21
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4646.21
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0546.21
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2861.81
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522555.25
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.251.06
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6469.05
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0854.51
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.842.14
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1543.9
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2228.92
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1226.51
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1926.9
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4813.98
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8928.46
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9326.02
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4132.32
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8426.18
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4425.42
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9244.39
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8446.72
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.447.77
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2847.84
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5948.75
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3755.17
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9246.21
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9949.74
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1637.44
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018853.13
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9251.93
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2965.77
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8978.37
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8778.37
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.178.37
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0978.37
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7775.47
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6675.47
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.975.47
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6275.47
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6187.81
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0287.81
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.687.81
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8487.81
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9587.81
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9587.81
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4475.15
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.578.48
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2468.56
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4369.64
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1559.25
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8759.25
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.359.25
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2859.25
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2659.25
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.258.64
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1560.92
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8860.92
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.460.83
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0960.92
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4160.92
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1660.12
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2648.29
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1457.01
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.257.01
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7357.01
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0457.01
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0457.01
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5759.51
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5659.51
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0459.51
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6759.51
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5559.51
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4460.65
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8153.45
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8534.89
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4534.89
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1734.89
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0734.89
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.732.5
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3841.31
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8841.31
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1341.31
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2641.31
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72107.19Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21107.19Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17107.19Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79142.58Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21142.58Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK